Get the Stockscreener App
208.11
1.25%
2.6634
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $208.11, with a volume of 852.13K.
It is up +1.25% in the last 24 hours and up +4.62% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$205.45
Open:
$205.47
24h Volume:
852.13K
Relative Volume:
0.38
Market Cap:
$49.45B
Revenue:
$234.31B
Net Income/Loss:
$1.61B
P/E Ratio:
31.42
EPS:
6.6243
Net Cash Flow:
$4.45B
1W Performance:
+0.39%
1M Performance:
+4.62%
6M Performance:
+26.13%
1Y Performance:
+73.89%
1-Day Range:
$205.06
$209.44
1-Week Range:
$201.02
$209.44
52-Week Range:
$119.11
$214.93
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
208.12 | 48.81B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
827.15 | 101.82B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
346.58 | 66.14B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
78.75 | 9.25B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.35 | 818.31M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health, Inc. $CAH Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5 - Cardinal Health
Cardinal Health (CAH) repositions for growth with specialty and services - MSN
Palliative Care Market See Incredible Growth 2025-2032 | - openPR.com
Cardinal Health (CAH) Repositions for Growth with Specialty and Services - Insider Monkey
Cardinal Health's quarterly earnings preview: What you need to know - MSN
Cardinal Health's Quarterly Earnings Preview: What You Need to Know - Barchart.com
User | chroniclejournal.comCardinal Health's Quarterly Earnings Preview: What You Need to Know - FinancialContent
Cardinal Health Ceo Salary Email Address Net Worth Michael Kaufmann Wiki- - shababeek.org
Hennessy Advisors Inc. Sells 4,900 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Diversified Trust Co Decreases Stake in Cardinal Health, Inc. $CAH - MarketBeat
List of 30 Acquisitions by Cardinal Health (Jan 2026) - Tracxn
Traders Purchase High Volume of Call Options on Cardinal Health (NYSE:CAH) - MarketBeat
The Truth About Cardinal Health Inc.: Quiet Stock, Loud Moves – Are You Sleeping On This Play? - AD HOC NEWS
February 2026 Options Now Available For Cardinal Health (CAH) - Nasdaq
Ex-Dividend Reminder: Sysco, Choice Hotels International and Cardinal Health - Nasdaq
Shilanski & Associates Inc. Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Short Interest Down 22.2% in December - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Simplify Asset Management Inc. - MarketBeat
U.S. Embolic Protection Devices Market and Competition - GlobeNewswire
U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More - Yahoo Finance
Valley National Advisers Inc. Has $97,000 Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Sowell Financial Services LLC Sells 9,987 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Vontobel Holding Ltd. Sells 33,101 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Here's What We Like About Cardinal Health's (NYSE:CAH) Upcoming Dividend - simplywall.st
Why You Might Be Interested In Cardinal Health, Inc. (NYSE:CAH) For Its Upcoming Dividend - Yahoo Finance
Columbus Macro LLC Has $5.73 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Pacer Advisors Inc. Lowers Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (FRA:CLH) EV-to-OCF : 10.24 (As of Dec. 25, 2025) - GuruFocus
Cardinal Health, Inc. $CAH Shares Sold by Swedbank AB - MarketBeat
Cardinal Health Earnings Notes - Trefis
Jim Cramer says “I like Cencora a lot” but notes “Cardinal Health’s got them all beat” - MSN
Here's Why Cardinal Health (CAH) is a Strong Growth Stock - Nasdaq
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences - The Globe and Mail
Yousif Capital Management LLC Lowers Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (CAH): Evaluating Valuation After Revenue Beat and Growing Optimism in Healthcare Services - Sahm
Cardinal Health (CAH): Rethinking Valuation After a Strong Multi‑Year Share Price Run - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Cardinal Health Inc. stock remains a top recommendationWeekly Gains Report & Growth Focused Entry Reports - Улправда
Wedge Capital Management L L P NC Sells 37,487 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Voya Investment Management LLC Has $128.98 Million Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Board of the Pension Protection Fund - MarketBeat
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know - sharewise.com
Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" - Finviz
Jim Cramer Says “I like Cencora A Lot” But Notes “Cardinal Health’s Got Them All Beat” - Insider Monkey
Is Cardinal Health Inc. stock positioned well for digital economy2025 Major Catalysts & Weekly Momentum Picks - DonanımHaber
How Cardinal Health Inc. (CLH) stock trades in high volatilityJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - DonanımHaber
Cardinal Health (CAH) Continues to Benefit from Rising Demand - Finviz
Will Cardinal Health Inc. stock recover faster than industryWeekly Trade Report & Verified Short-Term Plans - Улправда
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
9.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):